We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RYTM market cap is 3.47B. The company's latest EPS is USD -3.0050 and P/E is -18.81.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 22.5M | 24.23M | 25.97M | 29.08M | 33.25M |
| Operating Income | -43.97M | -41.27M | -139.89M | -40.48M | -43.89M |
| Net Income | -44.16M | -41.63M | -141.37M | -33.56M | -45.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 3.15M | 23.64M | 77.43M |
| Operating Income | -146M | -136.58M | -170.06M | -179.16M | -184.36M |
| Net Income | -140.73M | -134M | -69.61M | -181.12M | -184.68M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 354.2M | 332.75M | 258.65M | 381.85M | 363.57M |
| Total Liabilities | 156.73M | 162.99M | 197.07M | 202.35M | 210.88M |
| Total Equity | 197.47M | 169.76M | 61.58M | 39.34M | 11.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 308.52M | 187.07M | 329.52M | 382.48M | 332.75M |
| Total Liabilities | 27.5M | 20.55M | 45.37M | 118.22M | 162.99M |
| Total Equity | 281.02M | 166.53M | 284.15M | 264.26M | 169.76M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -106.77M | -136.16M | -40.74M | -69.82M | -95.03M |
| Investing | -28.31M | -5.67M | 30.05M | 21.49M | -69.33M |
| Financing | 71.95M | 74.37M | 4.24M | 150.42M | 152.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -122.75M | -121.98M | -146M | -173.43M | -136.16M |
| Investing | -27.97M | 158.53M | -62.16M | 28.03M | -5.67M |
| Financing | 163.47M | 2.01M | 166.48M | 213.83M | 74.37M |
| Market Cap | 3.47B |
| Price to Earnings Ratio | -18.81 |
| Price to Sales Ratio | 44.87 |
| Price to Cash Ratio | 57.83 |
| Price to Book Ratio | 20.47 |
| Dividend Yield | - |
| Shares Outstanding | 61.46M |
| Average Volume (1 week) | 801.49k |
| Average Volume (1 Month) | 551.78k |
| 52 Week Change | 20.27% |
| 52 Week High | 68.58 |
| 52 Week Low | 35.17 |
| Spread (Intraday) | 1.45 (2.56%) |
| Company Name | Rhythm Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.rhythmtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
